<DOC>
	<DOC>NCT01601951</DOC>
	<brief_summary>The purpose of this study is to determine if Bone Marrow Concentrate may be successful in the treatment of osteoarthritis. Bone Marrow Concentrate is known to contain a community of cells that has been shown to have "regenerative" properties. This study is designed to evaluate the short-term clinical and x-ray outcomes of injections for hip and knee osteoarthritis. Inclusion Criteria: - Subjects must be scheduled for an autologous bone marrow hip or knee injection - Subjects must have a diagnosis of hip or knee osteoarthritis - Subjects must be between the ages of 18 and 85 - Subjects must be willing and able to sign Informed Consent - Subjects must be willing and able to return for scheduled follow-up evaluations Exclusion Criteria: - Subjects who have had any type of visco-supplementation in the treated joint within the last three months prior to enrollment - Subjects for whom baseline data is not available</brief_summary>
	<brief_title>Outcomes Data of Bone Marrow Stem Cells to Treat Hip and Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>Subjects must be scheduled for an autologous bone marrow hip or knee injection Subjects must have a diagnosis of hip or knee osteoarthritis Subjects must be between the ages of 18 and 85 Subjects must be willing and able to sign Informed Consent Subjects must be willing and able to return for scheduled followup evaluations Subjects who have had any type of viscosupplementation in the treated joint within the last three months prior to enrollment Subjects for whom baseline data is not available</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Stem Cell Injections</keyword>
	<keyword>Bone Marrow</keyword>
	<keyword>Autologous</keyword>
</DOC>